GMM Pfaudler Ltd announces Q4, FY2020 results
Chemical

GMM Pfaudler Ltd announces Q4, FY2020 results

The company's consolidated operating revenue increased to Rs. 5,911mn, up 18% versus Rs. 5,026mn in FY19.

  • By ICN Bureau | May 24, 2020
GMM Pfaudler (GMMP) a leading supplier of process equipment to the pharmaceutical and chemical industry segments today announced its fourth quarter (Q4FY20) and full year (FY20) results for the period ended March 31st, 2020.
 
Standalone Q4FY20 review (Y/Y %) 
- Operating revenue declined to Rs.1,134mn, down 6% versus Rs.1,207mn during Q4 of last year.
- EBITDA improved to Rs.202mn, up 19% versus Rs.170mn during Q4 of last year.
- EBITDA Margin improved to 18% versus 14% in Q4 of last year.
- Net profit declined to Rs.100mn, down 7% versus Rs.108mn during Q4 of last year.
 
Standalone FY20 review (Y/Y %) 
- Operating revenue increased to Rs.5,164mn, up 23% versus Rs.4,187mn in FY19.
- EBITDA improved to Rs.994mn, up 52% versus Rs.656mn in FY19.
- EBITDA Margin improved to 19% versus 16% in FY19.
- Net profit increased to Rs.621mn, up 53% versus Rs.406mn in FY19.
 
Consolidated Q4FY20 review (Y/Y %) 
- Operating revenue declined to Rs.1,318mn, down 5% versus Rs.1,391mn during Q4 of last year.
- EBITDA improved to Rs.225mn, up 14% versus Rs.198mn during Q4 of last year.
- EBITDA Margin improved to 17% versus 14% in Q4 of last year.
- Net profit declined to Rs.116mn, down 13% versus Rs.133mn during Q4 of last year.
 
Consolidated FY20 review (Y/Y %) 
- Operating revenue increased to Rs.5,911mn, up 18% versus Rs.5,026mn in FY19.
- EBITDA improved to Rs.1,111mn, up 44% versus Rs.770mn in FY19.
- EBITDA Margin improved to 19% versus 15% in FY19.
- Net profit increased to Rs.711mn, up 41% versus Rs.506mn in FY19.
 
Commenting on the Company's performance for Q4FY20, Tarak Patel, Managing Director said "We are pleased to announce robust performance in the last quarter of the fiscal year despite external challenges imposed by the coronavirus outbreak. We have been relatively insulated from the current disruption as our order backlog continues to remain strong and we expect to meet our production targets as per our earlier plans. We expect increased activity in the pharma and chemical industry resulting in a sustained demand environment."
 
He further added "We remain focused as we set out to take the Company to next level of growth."

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization